Applied DNA Sciences, Inc. (APDN)

USD 0.23

(1.26%)

Total Debt Summary of Applied DNA Sciences, Inc.

  • Applied DNA Sciences, Inc.'s latest annual total debt in 2023 was 1.23 Million USD , down 0.0% from previous year.
  • Applied DNA Sciences, Inc.'s latest quarterly total debt in 2024 Q2 was 994.11 Thousand USD , down -11.03% from previous quarter.
  • Applied DNA Sciences, Inc. reported annual total debt of - USD in 2022, down 0.0% from previous year.
  • Applied DNA Sciences, Inc. reported annual total debt of - USD in 2021, down -100.0% from previous year.
  • Applied DNA Sciences, Inc. reported quarterly total debt of 1.11 Million USD for 2024 Q1, down -9.73% from previous quarter.
  • Applied DNA Sciences, Inc. reported quarterly total debt of 868.08 Thousand USD for 2024 Q3, down -12.68% from previous quarter.

Annual Total Debt Chart of Applied DNA Sciences, Inc. (2023 - 1998)

Historical Annual Total Debt of Applied DNA Sciences, Inc. (2023 - 1998)

Year Total Debt Total Debt Growth
2023 1.23 Million USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 2.34 Million USD 51.82%
2019 1.54 Million USD -2.61%
2018 1.58 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 1.8 Million USD 0.0%
2013 - USD 0.0%
2012 - USD -100.0%
2011 3.73 Million USD 110.3%
2010 1.77 Million USD -26.4%
2009 2.41 Million USD -21.31%
2008 3.06 Million USD 313.73%
2007 740.4 Thousand USD -91.49%
2006 8.7 Million USD 2020.46%
2005 410.42 Thousand USD -85.28%
2004 2.78 Million USD 3050.85%
2003 88.5 Thousand USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%

Peer Total Debt Comparison of Applied DNA Sciences, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 98.593%
Prenetics Global Limited 2.36 Million USD 47.76%
Star Equity Holdings, Inc. 3.6 Million USD 65.704%
CareDx, Inc 34.22 Million USD 96.383%
Exact Sciences Corporation 2.55 Billion USD 99.952%
Exagen Inc. 23.72 Million USD 94.782%
Inotiv, Inc. 417.64 Million USD 99.704%
Guardant Health, Inc. 1.35 Billion USD 99.909%
Biodesix, Inc. 60.69 Million USD 97.961%
BioNexus Gene Lab Corp. 133.39 Thousand USD -827.891%
Precipio, Inc. 1.11 Million USD -10.91%
iSpecimen Inc. 196.24 Thousand USD -530.725%
Natera, Inc. 441.99 Million USD 99.72%
Aspira Women's Health Inc. 2.26 Million USD 45.377%
Standard BioTools Inc. 98.21 Million USD 98.74%
23andMe Holding Co. 76.51 Million USD 98.382%
Castle Biosciences, Inc. 15.31 Million USD 91.915%
Personalis, Inc. 48.96 Million USD 97.472%
Aclaris Therapeutics, Inc. 426 Thousand USD -190.554%
OpGen, Inc. 13.04 Million USD 90.511%
T2 Biosystems, Inc. 49.49 Million USD 97.499%
Myriad Genetics, Inc. 145 Million USD 99.146%
ICON Public Limited Company 3.93 Billion USD 99.969%
NeoGenomics, Inc. 611.67 Million USD 99.798%
Star Equity Holdings, Inc. 3.6 Million USD 65.704%
IDEXX Laboratories, Inc. 947.88 Million USD 99.869%
RadNet, Inc. 1.49 Billion USD 99.917%
MDxHealth SA 41.26 Million USD 97.0%
Psychemedics Corporation 2.29 Million USD 46.138%
Illumina, Inc. 2.26 Billion USD 99.945%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 98.684%
DarioHealth Corp. 29.54 Million USD 95.81%
Fulgent Genetics, Inc. 14.9 Million USD 91.697%
Sera Prognostics, Inc. 1.85 Million USD 33.382%
ENDRA Life Sciences Inc. 394.4 Thousand USD -213.831%
OPKO Health, Inc. 326.56 Million USD 99.621%
Medpace Holdings, Inc. 142.12 Million USD 99.129%
Neogen Corporation 906.23 Million USD 99.863%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -42.036%
Prenetics Global Limited 2.36 Million USD 47.76%
Mainz Biomed B.V. 7.42 Million USD 83.32%
bioAffinity Technologies, Inc. 1.57 Million USD 21.593%
Trinity Biotech plc 67.42 Million USD 98.164%
Neuronetics, Inc. 62.47 Million USD 98.019%
Sotera Health Company 2.32 Billion USD 99.947%
bioAffinity Technologies, Inc. 1.57 Million USD 21.593%